Shared Decision-Making for Partial Oral Antibiotic Treatment of Infective Endocarditis: A Case Series-Reference-Cited by-同舟云学术

Shared Decision-Making for Partial Oral Antibiotic Treatment of Infective Endocarditis: A Case Series

Published:2024-03-19 Issue:4 Volume:11 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

El-Dalati Sami¹^ORCID,Castillo Marice Ruiz Conejo²,Strnad Luke³,Reda Hassan⁴,London Tessa⁴,Sekela Michael⁴,Stoner Bobbi Jo⁵

Affiliation:

1. Division of Infectious Diseases, Department of Internal Medicine, University of Kentucky Medical Center , Lexington, Kentucky , USA

2. CrescentCare , New Orleans, Louisiana , USA

3. Division of Infectious Diseases, Department of Internal Medicine, Oregon Health and Science University , Portland, Oregon , USA

4. Department of Cardiac Surgery, University of Kentucky College of Medicine , Lexington, Kentucky , USA

5. University of Kentucky College of Pharmacy , Lexington, Kentucky , USA

Abstract

Abstract Although literature has demonstrated the noninferiority of oral antibiotics in the treatment of infectious endocarditis, widespread adoption of this practice has yet to occur in the United States. We report on 32 patients with infectious endocarditis treated by a multidisciplinary endocarditis team and a standardized approach to partial oral antibiotic therapy with a high rate of clinical success.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofae166/57021098/ofae166.pdf

Reference17 articles.

1. Gender, age, and regional disparities in the incidence and mortality trends of infective endocarditis in the United States between 1990 and 2019;Mettler;Am J Cardiol,2023

2. Clinical and economic burden of hospitalizations for infective endocarditis in the United States;Alkhouli;Mayo Clin Proc,2020

3. Partial oral versus intravenous antibiotic treatment of endocarditis;Iversen;N Engl J Med,2019

4. Real-world application of oral therapy for infective endocarditis: a multicenter, retrospective, cohort study;Freling;Clin Infect Dis,2023

5. Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review;Wald-Dickler;Am J Med,2022